A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/48 (2006.01) A61P 9/10 (2006.01)
Patent
CA 2667664
The present invention relates to the use of a fusion protein comprising an antibody part which specifically recognises ED-B fibronectin, an effector part and optionally one or more fusion protein linker(s) and/or antibody linker(s), for the manufacturing of medicaments for the treatment and prevention of atherosclerosis.
La présente invention concerne l'utilisation d'une protéine de fusion comprenant une partie anticorps qui reconnaît spécifiquement la fibronectine ED-B, une partie effectrice et facultativement un ou plusieurs segments de liaison de protéine de fusion et/ou un ou plusieurs segments de liaison d'anticorps, pour la fabrication de médicaments pour le traitement et la prévention de l'athérosclérose.
Graf Kristof
Menrad Andreas
Menssen Hans Dietrich
Bayer Schering Pharma Aktiengesellschaft
Marks & Clerk
Philogen S.p.a.
LandOfFree
Use of a fusion protein targeting the ed-b fibronectin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a fusion protein targeting the ed-b fibronectin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a fusion protein targeting the ed-b fibronectin... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1549095